Skip to main content

An official website of the United States government

You have 2 new alerts

Flu Vaccine for the 2022-2023 Season at the VAGLAHS

Award Details

  • Contract Award Date: Apr 06, 2022
  • Contract Award Number: 36E79722D0009
  • Task/Delivery Order Number: 36C26222N0478
  • Contractor Awarded Unique Entity ID:
  • Contractor Awarded Name: Seqirus USA Inc.
  • Contractor Awarded Address: Summit, NJ 07901 USA
  • Base and All Options Value (Total Contract Value): $937,808.90

General Information

  • Contract Opportunity Type: Award Notice (Original)
  • Original Published Date: Apr 21, 2022 08:04 pm EDT
  • Inactive Policy: Manual
  • Original Inactive Date: May 06, 2022
  • Initiative:
    • None

Classification

  • Original Set Aside:
  • Product Service Code: 6505 - DRUGS AND BIOLOGICALS
  • NAICS Code:
    • 325412 - Pharmaceutical Preparation Manufacturing
  • Place of Performance:
    Los Angeles , CA 90073
    USA

Description

Seqirus USA, Inc. is the sole NAC FSS contract holder distributor for this pharmaceutical. No other distributor was identified with the means to meet the requirement at a fair and reasonable price. This was awarded as a FSS limited sources firm-fixed price delivery order against NAC Mandatory Contract 36E79722D0009 in accordance with FAR Part 8.405-6 Limited sources procedures.

Contact Information

Contracting Office Address

  • 335 E. German Rd SUITE 301
  • Gilbert , AZ 85297
  • USA

Primary Point of Contact

Secondary Point of Contact





History

  • May 06, 2022 11:55 pm EDTAward Notice (Original)